Back to Journals » Cancer Management and Research » Volume 10

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Total article views   HTML views PDF downloads Totals
7,428 Dovepress* 6,633+ 777 7,410
PubMed Central* 795 233 1,028
Totals 7,428 1,010 8,438
*Since 15 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar